Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Jak-Stat signaling pathway may play a role in the pathogenesis of cholesteatoma
Görkem Eskiizmir1, H Seda Vatansever2, Erdogan Ozgür1
1Department of Otolaryngology-Head & Neck Surgery, Celal Bayar University, Manisa, Turkey.
Purpose:
Jak-Stat signaling pathway is one of the major signal transduction cascades which regulates most of the cellular events such as cell proliferation, differentiation, cell migration and apoptosis. This study aims to determine the activity of Jak-Stat signaling pathway in the pathogenesis of cholesteatoma.
Materials And Methods:
Cholesteatoma and skin samples were obtained from 10 patients who underwent tympanomastoidectomy for chronic otitis media with cholesteatoma. Immunohistochemical analysis of cholesteatoma and skin was performed using anti-Jak1, anti-Jak2, anti-Jak3, anti-Stat1, anti-Stat2, anti-Stat3, anti-Stat4 and anti-Stat5 antibodies. The immunoreactivities in cholesteatoma and skin were quantified using H-score measurement and statistical comparison was performed.
Results:
Jak1, Jak2, Jak3, Stat1 and Stat3 immunoreactivities were not detected in cholesteatoma; in contrast to the skin (129.8; 226.7; 33.0; 66.4;115.9). In addition, when H-score measurements of Stat2, Stat4 and Stat5 immunoreactivities were compared between cholesteatoma (172.8; 166.7; 120.0) and skin (400.0; 284.9; 292.0), statistically significant differences were found (p<0.0001, p<0.0001, p<0.0001).
Conclusions:
A remarkable deficiency in the family members of Jak-Stat signaling pathway was demonstrated in cholesteatoma. Therefore, perturbations in Jak-Stat signaling pathway may play a role in the pathogenesis of cholesteatoma.
Insights
The Janus kinase-Signal transducer and activator of transcription (Jak-Stat) signaling pathway shows a significant deficiency in cholesteatoma tissue compared to normal skin. This suggests that disruptions in this pathway may contribute to cholesteatoma development.
Area of Science:
- Cellular biology
- Molecular biology
- Otolaryngology
Background:
- The Janus kinase-Signal transducer and activator of transcription (Jak-Stat) signaling pathway is crucial for regulating cellular processes like proliferation, differentiation, migration, and apoptosis.
- Dysregulation of cellular signaling pathways is implicated in various pathological conditions.
Purpose of the Study:
- To investigate the activity and expression of key components of the Jak-Stat signaling pathway in cholesteatoma.
- To determine the potential role of Jak-Stat pathway alterations in the pathogenesis of cholesteatoma.
Main Methods:
- Immunohistochemical analysis was performed on cholesteatoma and adjacent skin samples from 10 patients.
- Antibodies against Jak1, Jak2, Jak3, Stat1, Stat2, Stat3, Stat4, and Stat5 were used.
- Immunoreactivity was quantified using H-score measurements and statistically analyzed.
Main Results:
- Jak1, Jak2, Jak3, Stat1, and Stat3 were not detected in cholesteatoma samples.
- Significantly lower immunoreactivity for Stat2, Stat4, and Stat5 was observed in cholesteatoma compared to skin samples (p<0.0001 for all).
Conclusions:
- A notable deficiency in Jak-Stat signaling pathway members was found in cholesteatoma.
- Perturbations in the Jak-Stat pathway are likely involved in the pathogenesis of cholesteatoma.
Related Concept Videos
The JAK-STAT Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway

